Findings of post hoc analyses published in JAMA Ophthalmology suggest that preoperative Scheimpflug imaging can help predict corneal edema resolution following Descemet membrane endothelial ...

DelveInsight's Persistent Corneal Edema Market Insights report includes a comprehensive understanding of current treatment practices, persistent corneal edema emerging drugs, market share of ...

Company also completes Phase 1 epithelial study to evaluate the safety of topical TTHX1114 to reduce the duration and impact of corneal epithelial defects SAN DIEGO--(BUSINESS WIRE)--Trefoil ...

Please provide your email address to receive an email when new articles are posted on . A 79-year-old woman was referred to the Cornea Service for progressive corneal edema and decreased vision in the ...

Please provide your email address to receive an email when new articles are posted on . There is a “wow” effect from refractive cataract surgery because we can eliminate the lens opacity and address ...

Epioxa ™ HD 0.239% / Epioxa ™ 0.177% (riboflavin 5’-phosphate ophthalmic solution) is now available for use in epithelium-on ...

Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) is a revolutionary surgical procedure that allows replacement of the diseased endothelium in cases of endothelial corneal dystrophies ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Findings from a pioneering study in The American Journal of Pathology, published by Elsevier, reveal that administration of the neuropeptide α-melanocyte-stimulating hormone (α-MSH) promotes corneal ...

Hazy vision is a symptom of corneal edema secondary to endothelial dysfunction. (Aurion Biotech Image) Aurion Biotech has raised $120 million to advance its cell therapy for an eye disorder that ...

SAN DIEGO--(BUSINESS WIRE)--Trefoil Therapeutics, a clinical-stage biotechnology company focused on developing novel new therapeutic agents to treat corneal diseases, today announced a series of data ...